Adherence to antiretroviral therapy (ART) is crucial for effective treatment, but can be quite complex. Non-adherence can adversely affect treatment outcomes. Although many studies have been done on adherence in the general population, few have included HIV-positive pregnant and postpartum women in resource-constrained settings. This review assessed the evidence on adherence among these groups of women. A systematic search of databases was completed between June and July 2011. Both qualitative and quantitative studies were included. Eighteen studies from a total of 6622 satisfied the inclusion criteria that included inter alia facilitators and barriers to adherence. This review highlighted that there is still no consensus on the definition and measurement of adherence; also multiple factors can affect a woman's ability to adhere to ART. Some of the barriers and facilitators identified were similar in both the type of study (qualitative and quantitative) and among the various countries. Findings indicated that the few studies in this population are conducted primarily in resource-rich settings. Such paucity of information warrants urgent attention; thus targeted research is needed to provide insight on adherence within this population.
DiMatteoMR. Variations to patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care2004;42:200–9
2.
MoriskyDEGreenLWLevineDM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care1986;24:67–74
3.
ChesneyM. Adherence to HAART regimens. AIDS Patient Care STDS2003;17:169–77
4.
PatersonDLSwindellsSMohrJAdherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med2000;133:21–30
5.
TurnerBJ. Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. J Infect Dis2002;185(Suppl. 2):143–51
6.
BangsbergDR. Less than 95% adherence to nonnucleoside reverse transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis2006;43:939–41
7.
Battaglioli-DeNeroAM. Strategies for improving patient adherence to therapy and long-term patient outcomes. J Assoc Nurses AIDS Care2007;18(1S):S17–22
8.
NewellML. Current issues in the prevention of mother-to-child transmission of HIV-1 infection. Trans R Soc Trop Med Hyg2006;100:1–5
9.
World Health Organization. PMTCT Strategic Vision 2010–2015: Preventing Mother-to-child Transmission of HIV to Reach the UNGASS Millennium Goals. 2010. See See http://whqlibdoc.who.int/publications/2010/9789241599030_eng.pdf(accessed May 2011)
10.
SethiAKCelentanoDDGangeSJMooreRDGallantJE. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis2003;37:1112–8
11.
BarclayTRHinkinCHCastellonSAAge-associated predictors of medication adherence in HIV-positive adults: Health beliefs, self-efficacy, and neurocognitive status. Health Psychol2007;26:40–9
12.
PoppaADavidsonODeutschJBritish HIV Association (BHIVA)/British Association for Sexual Health and HIV (BASHH) Guidelines on provision of adherence support to individuals receiving antiretroviral therapy (2003). HIV Med2004;5:46–60
13.
HorneRCooperVGellaitryGDateHLFisherM. Patients’ perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. J Acquir Immune Defic Syndr2007;45:334–41
14.
HorneRWeinmanJ. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res1999;47:555–67
15.
HorneR. Patients’ beliefs about treatment: the hidden determinant of treatment outcome. J Psychosom Res1999;47:491–5
16.
HorneRGraupnerLFrostSWeinmanJWrightSMHankinsM. Medicine in a multi-cultural society: the effect of cultural background on beliefs about medications. Soc Sci Med2004;59:1307–13
17.
World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: 2010 Revision. 2010. See http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf(accessed March 2012)
18.
BalfourLKowalJSilvermanAA randomized controlled psycho-education intervention trial: Improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART. AIDS Care2006;18:830–8
19.
NordqvistOSodergardBTullyMPSonnerborgALindbladAK. Assessing and achieving readiness to initiate HIV medication. Patient Educ Couns2006;62:21–30
20.
FowlerME. Recognizing the phenomenon of readiness: concept analysis and case study. J Assoc Nurses AIDS Care1998;9:72–6
21.
BangsbergDRHechtFMClagueHProvider assessment of adherence to antiretroviral therapy. J Acquir Immune Defic Syndr2001;26:435–42
22.
BeckerMH. Patient adherence to prescribed therapies. Med Care1985;23:539–55
23.
WagnerGJRabkinJG. Measuring medication adherence: are missed doses reported more accurately than perfect adherence?AIDS Care2000;12:405–8
24.
MartinJEscobarIRubioRSabugalGCasconJPulidoF. Study of the validity of a questionnaire to assess the adherence to therapy in patients infected by HIV. HIV Clin Trials2001;2:31–7
25.
ArnstenJHDemasPAFarzadeganHAntiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self report and electronic monitoring. Clin Infect Dis2001;33:1417–23
26.
SherrLLampeFNorwoodSAdherence to antiretroviral treatment in patients with HIV in the UK: a study of complexity. AIDS Care20:442–8
MannheimerSFriedlandGMattsJChildCChesneyM. The consistency of adherence to antiretroviral therapy predicts biologic outcome for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis2002;34:1115–21
29.
FarmerKC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther1999;21:1074–90
30.
HillZKendallCFernandezM. Patterns of adherence to antiretrovirals: why adherence has no simple measure. AIDS Patient Care STDS2003;17:519–25
31.
SherrLLampeFCClucasCSelf-reported non-adherence to ART and virological outcome in a multi-clinic UK study. AIDS Care2010;22:939–45
32.
LiberatiAAltmanDGTetzlaffJThe PRISMA Statement for reporting systematic reviews and meta-analysis of studies that evaluate health care interventions: explanation and elaboration. PLoS Med2009;6:1–28
33.
HigginsJGreenS. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. [updated March 2011]. The Cochrane Collaboration. 2011. See http://www.cochrane-handbook.org/(accessed July 2011)
34.
ArmstrongRWatersEJacksonNGuidelines for systematic reviews of health promotion and public health interventions. Version 2. [pdf] Australia: Melbourne University. 2007. See http://ph.cochrane.org/sites/ph.cochrane.org/files/uploads/GuidelinesHP_PHreviews.pdf(accessed July 2011)
35.
MephamSZondiZMbuyaziAMkhwanaziNNewellML. Challenges in PMTCT antiretroviral adherence in northern KwaZulu-Natal, South Africa. AIDS Care2011;23:741–7
36.
CohnSEUmblejaTMrusJBardeguezADAndersonADChesneyMA. Prior illicit drug use and missed prenatal vitamins predict non-adherence to antiretroviral therapy in pregnancy: adherence analysis A5084. AIDS Patient Care STDS2008;22:29–40
37.
WilsonTEIckovicsJRFernandezMIKoenigLJWalterE. Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US States. Am J Obstet Gynecol2001;184:1235–40
38.
IckovicsJRWilsonTERoyceRAPrenatal and postpartum Zidovudine adherence among pregnant women with HIV. J Acquir Immune Defic Syndr2002;30:311–5
39.
MellinsCAChuCMaleeKAdherence to antiretroviral treatment among pregnant and postpartum HIV-infected women. AIDS Care2008;20:958–68
40.
PeltzerKMlamboMPhaswana-MafuyaNLadzaniR. Determinants of adherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Gert Sibande district in South Africa. Acta Pædiatrica2010;99:699–704
41.
KirstenISewangiJKunzAAdherence to combination prophylaxis for Prevention of Mother-to-Child-Transmission of HIV in Tanzania. PLoS One2011;6:1–9
42.
DemasPATheaDMWeedonJAdherence to Zidovudine for the prevention of perinatal transmission in HIV-infected pregnant women: the impact of social network factors, side effects, and perceived treatment efficacy. Women Health2005;42:99–115
43.
TurnerBJNewschafferCJZhangDCoslerLHauckWH. Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women. Med Care2000;38:911–25
44.
DelvauxTElulBNdagijeFMunyanaERoberfroidDAsiimweA. Determinants of non-adherence to a single-dose nevirapine regimen for the prevention of Mother-to-Child HIV transmission in Rwanda. J Acquir Immune Defic Synd2009;50:223–30
45.
LaineCNewschafferCJZhangDCoslerLHauckWWTurnerBJ. Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis. Obstet Gynecol2000;95:167–73
46.
BiiSCOtieno-NyunyaBSiikaARotichJK. Self-reported adherence to single dose Nevirapine in the prevention of mother to child of HIV at Kitale District Hospital. East Afr Med J2007;84:571–6
47.
VazMJBarrosSMPalaciosRHIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women. Int J STD AIDS2007;18:28–32
48.
AlbrechtSSemrauKKasondePPredictors of non-adherence to single-dose Nevirapine therapy for the prevention of mother-to-child HIV transmission. J Acquir Immune Defic Syndr2006;41:114–8
49.
BardeguezADLindseyJCShannonMAdherence to antiretrovirals among US women during and after pregnancy. J Acquir Immune Defic Syndr2008;48:408–17
50.
DuffPKippWWildTCRubaaleTOkech-OjonyJ. Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda. J Int AIDS Soc2010;13:1–9
51.
CiambroneDALoewenthalHGBazermanLBZorillaCUrbinaBMittyJA. Adherence among women with HIV infection in Puerto Rico: the potential use of modified directly observed therapy (MDOT) among pregnant and postpartum women. Women Health2006;44:61–77
52.
McDonaldKKirkmanM. HIV-positive women in Australia explain their use and non-use of antiretroviral therapy in preventing mother-to-child transmission. AIDS Care2011;23:578–84
53.
NachegaJBKnowltonARDelucaATreatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults: a qualitative study. J Acquir Immune Defic Syndr2006;43:S127–33
54.
GoujardCBernardNSohierNImpact of a patient education program on adherence to HIV medication. J Acquir Immune Defic Syndr2003;34:191–4
55.
MunyaoPLuchtersSChersichMFImplementation of clinic-based modified-directly observed therapy (m-DOT) for ART: experiences in Mombasa, Kenya. AIDS Care2010;22:187–94
56.
Pop-ElechesCThirumurthyHHabyarimanaJPMobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS2011;25:825–34
57.
daCostaTMBarbosaBJeCostaDAResults of a randomized controlled trial to assess the effects of a mobile SMS-based intervention on treatment adherence in HIV/AIDS-infected Brazilian women and impressions and satisfaction with respect to incoming messages. Int J Med Inf2012;81:257–69
